LOS ANGELES TIMES (LT) - MONDAY October 31, 1988 Edition: Home Edition Section: ONE Page: 3 Pt. 1 Col. 1 Word Count: 343
Janny Scott; Times Medical Writer
The study, by researchers at UC San Francisco, may help explain the observed link between hepatitis B and AIDS, acquired immune deficiency syndrome. The finding also suggests that people who are uninfected but at high risk for exposure to HIV might benefit by vaccination against hepatitis B, the researchers said.
"We're hoping, if we can understand this mechanism, we can . . . possibly prevent progression of AIDS in (certain) infected individuals," said Dr. T.S. Benedict Yen, an author of the study in the November issue of Proceedings of the National Academy of Sciences.
However, Yen warned that vaccination could be risky for people already infected with HIV. The vaccine could stimulate the immune system and possibly encourage proliferation of HIV.
Scientists have long suspected links between AIDS and hepatitis B, in part because most people with AIDS are also infected with hepatitis B. They say hepatitis B may be one of a number of co-factors in AIDS development, perhaps contributing to the onset of symptoms.
In one earlier study, homosexual men who had been previously vaccinated against hepatitis B were less likely than unvaccinated men to have developed AIDS. Yen said he is now exploring whether hepatitis B vaccination might be advisable for people at high risk for exposure to HIV.
In the study, published today, Yen's team placed cloned fragments of hepatitis B virus in human cell cultures containing cloned HIV. They found that the so-called "X protein" of the hepatitis B virus triggered HIV gene expression, which in turn prompts replication of the virus. The X protein exerted 10 times the effect on HIV of other virus products, they found.
"Although confirmatory clinical studies need to be done, these observations could explain the high correlation between HBV infection and AIDS and have implications for the treatment and prevention of AIDS," the researchers wrote.
Copyright © 1988 - Los Angeles Times. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Los Angeles Times, Permissions, Times Mirror Square, Los Angeles, CA 90053. http://www.latimes.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .